spantide II [7407]
spantide II
| SMILES | CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](N)Cc1ccc(Cl)c(Cl)c1)C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](N)CCCCNC(=O)c1cccnc1)C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1cccnc1 |
| InChIKey | AZZJAARMZMEIHY-BBKUSFMUSA-N |
| Sequence | KPAPFNWFWLX |
Chemical Properties
| Hydrogen bond acceptors | 18 |
| Hydrogen bond donors | 13 |
| Rotatable bonds | 40 |
| Log P | 4.726 |
| Molecular weight (Da) | 1666.7 |
| Stereochemistry info | unspecified |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
spantide II
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0